GENESIS Pharma S.A.

Santhera Pharmaceuticals says that its Duchenne muscular dystrophy (DMD) treatment Agamree has got off to a strong start and while pricing negotiations are unsurprisingly proving tricky, the Swiss fi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Ikena Cuts Back As BMS Unravels Partner

The Spanish biotech company Pharmamar, has its sights set on expansion and has opened its first operations outside its home market in Italy. The firm's managing director, Luis Mora, spoke to Scrip a